Ensuring Access to Generic Medications Act

This bill creates a legal process allowing generic drug manufacturers to challenge inaccurate patent listings by brand-name drug companies. Specifically, it permits generic applicants to file lawsuits seeking court orders to correct or delete misleading "use codes" in patent records related to a drug's method of use. This directly affects generic drug makers and brand-name sponsors who list patents for drug applications under FDA approval pathways. The key mechanism requires courts to address listings that don't match actual patents, cover unrelated uses, or are overly broad, aiming to clear patent-related barriers for generic competition.